In vitro hemocompatibility studies of drug-loaded poly-(L-lactic acid) fibers.
暂无分享,去创建一个
R C Eberhart | K. Nguyen | R. Eberhart | L Tang | N. Schwade | L. Tang | K T Nguyen | P. Greilich | D. Wawro | S-H Su | A Sheng | D Wawro | N D Schwade | C F Brouse | P E Greilich | S. Su | C. Brouse | A. Sheng
[1] J. Gallin,et al. Effects of taxol on human neutrophils. , 1982, Journal of immunology.
[2] T. Kirikae,et al. Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages. , 1998, Biochemical and biophysical research communications.
[3] J. Ting,et al. Taxol-dependent Transcriptional Activation of IL-8 Expression in a Subset of Human Ovarian Cancer , 1996 .
[4] S. Vogel,et al. Paclitaxel (Taxol)-induced NF-kappaB translocation in murine macrophages , 1996, Infection and immunity.
[5] C. Di Mario,et al. First Clinical Experience With a Paclitaxel Derivate–Eluting Polymer Stent System Implantation for In-Stent Restenosis: Immediate and Long-Term Clinical and Angiographic Outcome , 2002, Circulation.
[6] C. Beythien,et al. In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. , 2000, Thrombosis research.
[7] P. Hjemdahl,et al. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. , 1999, Cytometry.
[8] T. Meinertz,et al. Tantalum stents induce expression of GMP140 and GP53 on platelets after contact in an in vitro model. , 1996, Beitrage zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine.
[9] Donald L. Wise,et al. Biomaterials and Bioengineering Handbook , 2000 .
[10] T. Meinertz,et al. Influence of stent length and heparin coating on platelet activation: a flow cytometric analysis in a pulsed floating model. , 1999, Thrombosis research.
[11] Liping Tang,et al. Review: Bioresorbable polymeric stents: current status and future promise , 2003, Journal of biomaterials science. Polymer edition.
[12] M. Jeong,et al. Porcine model of stent thrombosis: platelets are the primary component of acute stent closure. , 1996, Catheterization and cardiovascular diagnosis.
[13] Á. Pascual,et al. Effect of paclitaxel alone or in combination on the intracellular penetration and activity of quinolones in human neutrophils. , 1996, The Journal of antimicrobial chemotherapy.
[14] B. Ghosh,et al. Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. , 1999, International journal of immunopharmacology.
[15] L. Norgren,et al. Deposition of platelets and neutrophils in porcine iliac arteries after angioplasty and wallstent placement compared with angioplasty alone , 1994, CardioVascular and Interventional Radiology.
[16] H. Burt,et al. Calcium pyrophosphate dihydrate crystals activate MAP kinase in human neutrophils: inhibition of MAP kinase, oxidase activation and degranulation responses of neutrophils by taxol , 1997, Immunology.
[17] E. Lakatta,et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. , 1995, The Journal of clinical investigation.
[18] R. Park,et al. Enhancing and priming of macrophages for superoxide anion production by taxol. , 1998, Immunopharmacology and immunotoxicology.
[19] J. White,et al. Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. , 1998, The American journal of pathology.
[20] S. Horwitz,et al. Mechanism of action of taxol. , 1992, Trends in pharmacological sciences.
[21] N. Vermeulen,et al. Cytotoxicity and cytoprotective activities of natural compounds. The case of curcumin. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.
[22] J. White,et al. Morphometry of platelet internal contraction. , 1984, The American journal of pathology.
[23] W. van Oeveren,et al. Multilink Stent Promotes Less Platelet and Leukocyte Adhesion Than a Traditional Stainless Steel Stent , 2001, Journal of Investigative Medicine.
[24] W. J. van der Giessen,et al. Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. , 1998, Journal of the American College of Cardiology.
[25] A. Tárnok,et al. Rapid in vitro biocompatibility assay of endovascular stents by flow cytometry using platelet activation and platelet-leukocyte aggregation. , 1999, Cytometry.
[26] S. Goodman,et al. Sheep, pig, and human platelet-material interactions with model cardiovascular biomaterials. , 1999, Journal of biomedical materials research.
[27] B. H. Shah,et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. , 1999, Biochemical pharmacology.
[28] T. Horie,et al. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. , 1999, Pharmacological research.
[29] K. Karsch,et al. Antiproliferative stent coatings: Taxol and related compounds. , 1998, Seminars in interventional cardiology : SIIC.
[30] Elazer R. Edelman,et al. Drug-Eluting Stents in Preclinical Studies: Recommended Evaluation From a Consensus Group , 2002, Circulation.
[31] Huei-Wen Chen,et al. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells , 1998, British journal of pharmacology.
[32] A. Baumbach,et al. Stent‐based antirestenotic coatings (sirolimus/paclitaxel) , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[33] P. Casterella. Restenosis: an overview. , 2001, Frontiers of radiation therapy and oncology.
[34] T. Meinertz,et al. Flow cytometric analysis of coronary stent-induced alterations of platelet antigens in an in vitro model. , 1997, Thrombosis research.
[35] C. Gemmell. Activation of platelets by in vitro whole blood contact with materials: Increases in microparticle, procoagulant activity, and soluble P-selectin blood levels , 2001, Journal of biomaterials science. Polymer edition.
[36] E. Topol,et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. , 1996, Circulation.
[37] A. Küttner,et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. , 1997, Circulation.
[38] K. Nguyen,et al. Biomaterials and Stent Technology , 2003 .
[39] N. Crawford,et al. Electrokinetic, analytical and functional heterogeneity of circulating human platelets: separation of subpopulations by continuous flow electrophoresis after taxol stabilization. , 1989, Biochimica et biophysica acta.
[40] A. K. Singh,et al. Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell. , 1996, Cancer letters.
[41] R. Donehower,et al. Drug therapy : paclitaxel (Taxol) , 1995 .